A group of Medicare advisors generally supported maintaining procedure-volume requirements for physicians and hospitals as a basis for covering transcatheter aortic valve replacement (TAVR) procedures during a July 25 meeting. But some in the medical and device-maker community argued that the emphasis must shift away from volume and toward quality measures.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?